Key terms
About AKTX
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AKTX news
No recent press releases are available for AKTX
AKTX Financials
Key terms
Ad Feedback
AKTX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AKTX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range